FDA Inspection 1226030 — Seok Goo Cho, M.D., Ph.D.
The FDA completed an inspection of Seok Goo Cho, M.D., Ph.D. on Dec 8, 2023 in Seoul. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 8, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Seoul (Korea (the Republic of))
Additional Details
Clinical Investigator (CI)